Hinge Health (HNGE) EBIT (2024 - 2026)

Hinge Health's EBIT history runs 3 years deep, the most recent figure standing at $32.1 million for Q1 2026.

• In Q1 2026, EBIT rose 144.11% year-over-year to $32.1 million; the TTM figure through Mar 2026 stood at -$527.4 million (down 4269.15% YoY), while the FY2025 annual figure was -$546.4 million, down 1612.23% from the prior year.
• EBIT came in at $32.1 million for Q1 2026 at Hinge Health, up from $27.3 million in the prior quarter.
• In the past five years, EBIT ranged from a high of $32.1 million in Q1 2026 to a low of -$580.7 million in Q2 2025.
• A 3-year average of -$64.3 million and a median of $4.6 million in 2024 frame the typical range for EBIT.
• Across the five-year window, EBIT sank 3208.48% in 2025 and jumped 144.11% in 2026, its largest moves.
• Hinge Health's EBIT stood at $20.9 million in 2024, then jumped by 30.35% to $27.3 million in 2025, then grew by 17.66% to $32.1 million in 2026.
• According to Business Quant data, EBIT over the past three periods registered $32.1 million, $27.3 million, and -$6.1 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison